Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
The Biggest Challenges in Ophthalmology Today
A recent survey conducted by OBN on LinkedIn asked participants to identify the most pressing challenge facing the ophthalmology field today. The poll revealed that nearly half of the respondents believe patient access to care is the primary issue, followed…
New Consensus: Myopia Should Be Classified as a Disease
A new consensus report from the National Academies of Sciences, Engineering, and Medicine urges that myopia be classified as a disease requiring medical diagnosis. The report emphasizes the growing prevalence of myopia globally, which is projected to affect 5 billion…
Novel Treatment for Diabetic Retinopathy Shows Promise
Researchers at the University of Oklahoma Health Sciences and Memorial Sloan Kettering (MSK) Cancer Center have unveiled a novel approach to treating diabetic retinopathy that could potentially transform outcomes for patients at risk of blindness. Anti-Ceramide Immunotherapy: A Novel Treatment…
Johnson & Johnson Reaches 50M Children Globally
Johnson & Johnson, in partnership with the Lions Clubs International Foundation (LCIF), has successfully provided comprehensive eye health services to over 50 million children in underserved communities worldwide through the Sight For Kids program. The initiative, which began in 2002,…
COVID-19 and Eye Care: It’s Impact and Implications
COVID-19, a global pandemic caused by the SARS-CoV-2 virus, has affected nearly every aspect of healthcare, including eye care services. Since the virus was first identified in December 2019, it has caused significant disruptions in healthcare systems worldwide. This article…
Llama-Derived Antibody May Treat Retinitis Pigmentosa
A group of researchers from the University of California, Irvine, has made a significant discovery: an exceptional antibody that could pave the way for treating Retinitis Pigmentosa. This condition results in the deterioration of central vision, as well as night…
Brazilian Study Finds Low Occurrence of Ocular Metastases
In a retrospective study conducted by Brazilian investigators, concerns about the occurrence of ocular metastases were addressed. Led by first author Matheus Senna Pereira Ogata, MD, from the Department of Ophthalmology and Visual Sciences at the Paulista Medical School, Federal…
Common Eye Conditions – Names of Eye Diseases List
In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…
Fenofibrate Reduces Diabetic Retinopathy Risk by 27%
In a groundbreaking development for diabetes management, the LENS trial has revealed that fenofibrate, a medication typically used to lower cholesterol, can significantly reduce the risk of diabetic retinopathy progression by 27%. These findings were presented at the American Diabetes…
Researchers Discover Novel Approach to Combat Vision Loss
A discovery in the treatment of age-related macular degeneration (AMD) has been unveiled by Cirrus Therapeutics, in collaboration with the University of Bristol and London’s Global University Institute of Ophthalmology. Published on the cover of the esteemed journal Science Translational…